MAM
CALA

Meeder Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History

Meeder Asset Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-220
Closed -$18K – 2629
2020
Q1 		$18K Sell
220
-203
-48% -$24.2K ﹤0.01% 1294
2019
Q4 		$48K Buy
423
+374
+763% +$28.1K ﹤0.01% 1031
2019
Q3 		$3K Sell
49
-42
-46% -$3.36K ﹤0.01% 1912
2019
Q2 		$6K Buy
91
+32
+54% +$3.63K ﹤0.01% 1636
2019
Q1 		$8K Sell
59
-413
-88% -$43.4K ﹤0.01% 1307
2018
Q4 		$38K Buy
472
+423
+863% +$41.7K ﹤0.01% 889
2018
Q3 		$5K Buy
49
+39
+390% +$3.71K ﹤0.01% 1345
2018
Q2 		$990 Buy
10
+4
+67% +$453 ﹤0.01% 1491
2018
Q1 		$1K Sell
6
-15
-71% -$2.34K ﹤0.01% 1506
2017
Q4 		$4K Buy
21
+18
+600% +$4.61K ﹤0.01% 1395
2017
Q3 		$1K Buy
+3
New +$946 ﹤0.01% 1588

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's CALA Position: Q2 2020 in Review

Meeder Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2020, closing a stake of 220 shares — an estimated $18K sold.

Meeder Asset Management first reported a position in CALA in Q3 2017 and held it in 11 quarters. The position peaked at $48K in Q4 2019. 110 funds tracked by Wall St. Rank hold CALA as of Q2 2020.

  • Meeder Asset Management reported no remaining Calithera Biosciences, Inc position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 220 Calithera Biosciences, Inc shares in Q2 2020, an estimated $18K.
  • Meeder Asset Management first reported a position in Calithera Biosciences, Inc in Q3 2017 and held it in 11 quarters.
  • Meeder Asset Management's Calithera Biosciences, Inc position peaked at $48K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.